Serum levels of circulating microRNA-107 are elevated in patients with early-stage HCC.

Sven H LoosenMirco CastoldiMarkus Sebastian JördensSanchary RoyMihael VucurJennis KandlerLinda HammerichRaphael MohrFrank TackeTom F UlmerUlf P NeumannTom LueddeChristoph Roderburg

Published in: PloS one (2021)

Tumoral miR-107 expression levels are a potential prognostic marker in early stage HCC. Furthermore, we describe a potential role of circulating miR-107 levels as a diagnostic biomarker in patients with early-stage HCC.

Keyphrases

early stage
long non coding rna
cell proliferation
poor prognosis
sentinel lymph node
long noncoding rna
squamous cell carcinoma
risk assessment
binding protein